TICAROS
- Biotech or pharma, therapeutic R&D
TiCARos is a clinical-stage, JLABS portfolio biotechnology company advancing next-generation CAR-T therapies through proprietary platform technologies. Our lead clinical asset, TC011, utilizes the novel CLIP CAR platform and has shown promising results in Phase I studies up to the mid-dose cohort. Building on this foundation, we are expanding into solid tumors with IND-enabling programs powered by our unique immune-enhancement platforms, including Converter and Switchable CAR technologies.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}